Skip to main content
OpenTrials
Completed

NCT Number: NCT03937687

The Effects of a Combination of TeaCrine®, Dynamine, and Caffeine in Law Enforcement

The purpose of this randomized, placebo-controlled, three-condition, double-blind, between-subjects clinical trial is to determine and compare the effects of the combination of TeaCrine®, Dynamine, and caffeine to a placebo and caffeine condition on reaction time and target acquisition and accuracy. A secondary purpose is to observe the changes in hemodynamic variables in response to this combination.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–63 year

Sex eligibility

Male

Study type

Interventional

Phase

Early Phase 1

Primary location

Rutgers University Center for Health and Human Performance, New Brunswick, New Jersey, United States

Loading trial locations.

About this study

BASELINE ASSESSMENT:

  • Subjects will report to the University of South Carolina Sport Science Lab normally hydrated and having refrained from eating for minimum 2 hours prior.
  • Upon arrival, subjects will complete the informed consent and the Caffeine Frequency Questionnaire (CFQ) to assess their intake.
  • Subjects will have body composition assessed using air displacement plethysmography (Bod Pod, Cosmed, Inc.) using standardized procedures.
  • A salivary sample will be provided by each subject before beginning familiarization to analyze for presence of the CYP1A2 (caffeine) gene.
  • Subjects will be familiarized with the cognitive testing protocols using the Dynavision D2TM board and TRAZER Sports Simulator. They will complete a shortened version of the mentally fatiguing condition on the DynavisionTM to familiarize with the protocol. They will be able to complete 3 trials of reaction time using the simulation on the TRAZER.
  • Following this, subjects will then complete 3 trials of marksmanship assessment using the optical targetry system.

CONDITIONS:

  • Following exercise familiarization, subjects will be randomly assigned to the condition of placebo (P), caffeine (C), or combination of caffeine + TeaCrine + Dynamine (DC). Sessions will be scheduled at the same time as the initial baseline/familiarization session.
  • Subjects will be asked to maintain a normal sleep schedule in the week leading up to their session, maintaining the same wake time each day.
  • Subjects will be asked to refrain from alcohol for 48 hours and caffeine 24 hours prior to their condition, with no major changes in food intake.
  • Subjects will consume the supplement, complete the Multi-Component Training Distress Scale (MTDS) and will begin their session 30 minutes later.
  • Sessions will include 30 minutes of a mentally fatiguing task on the Dynavision D2TM board, designed with a go/no-go stimulus. The blinds will be drawn and lights switched off to reduce glare on the board.
  • At baseline and after each phase of the protocol, an assessment of psychological arousal will be taken using subjective measures of the Felt Arousal Scale (FAS) .
  • Subjects will then perform the reaction time assessment on the TRAZER and shooting assessment. This will be performed twice. The TRAZER will consist of 40 targets, and the shooting assessment will be 8 shots with a tactical re-load followed by an additional 8 shots. A 2-minute rest will be taken between trials. Total time allotted for assessments will be 20 minutes.
  • Subjects will then be seated in a room for 30 minutes, during which time they will read leisurely. At the completion of this time, subjects will complete the mentally fatiguing protocol once more (30 minutes). Following this, measures of reaction time and shooting assessment will be performed again (20 minutes).
  • Heart rate will be monitored and recorded throughout testing to establish average and peak values during the reaction time and marksmanship tasks.
  • Blood pressure will be measured pre- and post-testing using the Omron HEM 907XL Intellisense Pro Digital Blood Pressure cuff.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject has provided written and dated informed consent to participate in the study.
  • Subject is in good health as determined by physical examination and medical history.
  • Subject is between the ages of 18 and 63.
  • Subject is a current member of the military or law enforcement.

Exclusion criteria

  • Subjects who have injuries that would prevent them from completing the protocol.
  • Subjects who have migraine headaches.
  • Subjects with a history of kidney or liver disease.
  • Subjects with a history of caffeine sensitivity.
  • Subjects currently taking OTC products containing pseudoephedrine or other stimulants.
  • Subjects who drink more than four cups of coffee per day.

Treatment and study plan

Caffeine+TeaCrine+Dynamine

Drug

combination of caffeine, TeaCrine, and Dynamine

Other names: Combination

Placebo

Drug

Placebo

Caffeine

Drug

Caffeine

Primary outcomes

  1. Reaction time

    Time frame: 4 minutes, following the first 30-minute mental fatigue protocol

    Spatial reaction

  2. Reaction time

    Time frame: 4 minutes, following the second 30-minute mental fatigue protocol

    Spatial reaction

  3. Marksmanship

    Time frame: 2 minutes, following the first 30-minute mental fatigue protocol

    Simulated marksmanship using optical targetry

  4. Marksmanship

    Time frame: 2 minutes, following the second 30-minute mental fatigue protocol

    Simulated marksmanship using optical targetry

Secondary outcomes

  1. Blood pressure responses

    Time frame: 3 hours total

    Changes in blood pressure throughout the course of the protocol

  2. Heart rate responses

    Time frame: 3 hours total

    Changes in heart rate throughout the course the protocol

Sponsors and collaborators

Lead sponsor

University of South Carolina

Other

Collaborators

  • Compound Solutions Inc.
  • Rutgers, The State University of New Jersey

Registry information

Official study title

The Effects of a Combination of TeaCrine®, Dynamine, and Caffeine on Marksmanship Accuracy and Reaction Time in ROTC Members, Military, and Law Enforcement Following a Mentally Fatiguing Protocol

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
May 6, 2019
Registry last updated
Sep 30, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.